Back
Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. Krystal Biotech, Inc. Industry Stock Comparison
Buy
78
GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF
Last Price:
$133.47
Seasonality Move:
3.87%
Buy
75
KRYS
Krystal Biotech, Inc.
Last Price:
$248.58
Seasonality Move:
5.72%
Buy
78
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC)
is a Buy
Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?
-
The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $132.56. The Score for GSLC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
GSLC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Krystal Biotech, Inc. (KRYS)
is a Buy
Is Krystal Biotech, Inc. a Buy, Sell or Hold?
-
The current Krystal Biotech, Inc. [KRYS] share price is $240.80. The Score for KRYS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
KRYS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GSLC Stock Price Chart
What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?
-
The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $132.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GSLC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRYS Stock Price Chart
What is Krystal Biotech, Inc.'s stock price today?
-
The Krystal Biotech, Inc. share price today is $240.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight buying pressure.
GSLC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 55.09 | Buy |
| Chaikin Money Flow: | 136561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (129.1 - 133.06) | Buy |
| Bollinger Bands (100): | (126.51 - 131.89) | Buy |
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.84 | Buy |
| Relative Strength Index (14 RSI): | 68.35 | Buy |
| Chaikin Money Flow: | 226476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (210.18 - 238.06) | Buy |
| Bollinger Bands (100): | (150.15 - 213.59) | Buy |
GSLC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.26 | Buy |
| 20-day SMA: | 131.82 | Buy |
| 50-day SMA: | 130.89 | Buy |
| 200-day SMA: | 121.79 | Buy |
| 8-day EMA: | 132.01 | Buy |
| 20-day EMA: | 131.74 | Buy |
| 50-day EMA: | 128.69 | Buy |
| 200-day EMA: | 82.51 | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 240.33 | Buy |
| 20-day SMA: | 228.78 | Buy |
| 50-day SMA: | 208.63 | Buy |
| 200-day SMA: | 167.73 | Buy |
| 8-day EMA: | 237.28 | Buy |
| 20-day EMA: | 229.15 | Buy |
| 50-day EMA: | 210.93 | Buy |
| 200-day EMA: | 178.26 | Buy |
Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Krystal Biotech, Inc. Earnings Growth & KRYS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.76 per share.
Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Krystal Biotech, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||